Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 5.28598286 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 5.28598286 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.11781567 |
4 | protein retention in ER lumen (GO:0006621) | 3.76705507 |
5 | COPII vesicle coating (GO:0048208) | 3.72493663 |
6 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.58918792 |
7 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.32869594 |
8 | positive regulation of actin filament depolymerization (GO:0030836) | 3.24282503 |
9 | peptide hormone processing (GO:0016486) | 3.21880084 |
10 | L-phenylalanine catabolic process (GO:0006559) | 3.16453827 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.16453827 |
12 | signal peptide processing (GO:0006465) | 3.16015064 |
13 | detection of calcium ion (GO:0005513) | 3.13634072 |
14 | endocrine pancreas development (GO:0031018) | 3.10534964 |
15 | ER overload response (GO:0006983) | 3.05200371 |
16 | positive regulation of protein autophosphorylation (GO:0031954) | 3.04372153 |
17 | regulation of glucokinase activity (GO:0033131) | 2.95897860 |
18 | regulation of hexokinase activity (GO:1903299) | 2.95897860 |
19 | negative regulation of neurological system process (GO:0031645) | 2.95717251 |
20 | vesicle coating (GO:0006901) | 2.92195225 |
21 | exocrine pancreas development (GO:0031017) | 2.92100894 |
22 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.88953603 |
23 | zinc ion transport (GO:0006829) | 2.79875557 |
24 | L-phenylalanine metabolic process (GO:0006558) | 2.77580695 |
25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.77580695 |
26 | negative regulation of complement activation (GO:0045916) | 2.73629486 |
27 | cellular response to vitamin D (GO:0071305) | 2.71957150 |
28 | cell adhesion mediated by integrin (GO:0033627) | 2.71518481 |
29 | peroxisome fission (GO:0016559) | 2.71382333 |
30 | negative regulation of protein activation cascade (GO:2000258) | 2.69685912 |
31 | toxin metabolic process (GO:0009404) | 2.67738604 |
32 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.67370595 |
33 | positive regulation of nuclease activity (GO:0032075) | 2.64426969 |
34 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.61016428 |
35 | protein maturation by protein folding (GO:0022417) | 2.60329750 |
36 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.60249395 |
37 | protein targeting to Golgi (GO:0000042) | 2.58175288 |
38 | vascular smooth muscle contraction (GO:0014829) | 2.54484142 |
39 | * ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.53653961 |
40 | lipid particle organization (GO:0034389) | 2.51925145 |
41 | regulation of metalloenzyme activity (GO:0048552) | 2.50188546 |
42 | cellular zinc ion homeostasis (GO:0006882) | 2.49890229 |
43 | protein hydroxylation (GO:0018126) | 2.49338992 |
44 | cullin deneddylation (GO:0010388) | 2.48710436 |
45 | membrane budding (GO:0006900) | 2.47924021 |
46 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.47585216 |
47 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.45905033 |
48 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.44345611 |
49 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.43552467 |
50 | insulin secretion (GO:0030073) | 2.42990298 |
51 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.41643289 |
52 | tonic smooth muscle contraction (GO:0014820) | 2.41136552 |
53 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.41125246 |
54 | negative regulation of hormone metabolic process (GO:0032351) | 2.40984842 |
55 | cellular response to unfolded protein (GO:0034620) | 2.40816927 |
56 | valine metabolic process (GO:0006573) | 2.40610539 |
57 | C4-dicarboxylate transport (GO:0015740) | 2.40557419 |
58 | cellular response to leptin stimulus (GO:0044320) | 2.40384552 |
59 | peptidyl-proline hydroxylation (GO:0019511) | 2.40328438 |
60 | 4-hydroxyproline metabolic process (GO:0019471) | 2.39862917 |
61 | artery smooth muscle contraction (GO:0014824) | 2.39699458 |
62 | establishment of protein localization to Golgi (GO:0072600) | 2.39270128 |
63 | xenobiotic catabolic process (GO:0042178) | 2.36916073 |
64 | L-serine transport (GO:0015825) | 2.36525554 |
65 | ER-nucleus signaling pathway (GO:0006984) | 2.35570013 |
66 | cellular response to vitamin (GO:0071295) | 2.35174368 |
67 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.34577840 |
68 | protein localization to Golgi apparatus (GO:0034067) | 2.34002219 |
69 | protein localization to cilium (GO:0061512) | 2.32806330 |
70 | polyketide metabolic process (GO:0030638) | 2.32700355 |
71 | doxorubicin metabolic process (GO:0044598) | 2.32700355 |
72 | daunorubicin metabolic process (GO:0044597) | 2.32700355 |
73 | keratinocyte development (GO:0003334) | 2.31681801 |
74 | regulation of nuclease activity (GO:0032069) | 2.31059579 |
75 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.29848582 |
76 | endoplasmic reticulum organization (GO:0007029) | 2.28685275 |
77 | coenzyme catabolic process (GO:0009109) | 2.28327418 |
78 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.28315298 |
79 | platelet dense granule organization (GO:0060155) | 2.28111845 |
80 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.28108278 |
81 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.27631226 |
82 | peptidyl-cysteine modification (GO:0018198) | 2.27525050 |
83 | cerebellar Purkinje cell layer development (GO:0021680) | 2.26630547 |
84 | axoneme assembly (GO:0035082) | 2.26412095 |
85 | nucleoside diphosphate catabolic process (GO:0009134) | 2.26353105 |
86 | zinc ion transmembrane transport (GO:0071577) | 2.26090385 |
87 | cellular response to topologically incorrect protein (GO:0035967) | 2.25393604 |
88 | glandular epithelial cell differentiation (GO:0002067) | 2.24075336 |
89 | Golgi to plasma membrane protein transport (GO:0043001) | 2.23536520 |
90 | type B pancreatic cell proliferation (GO:0044342) | 2.23194123 |
91 | regulation of extracellular matrix disassembly (GO:0010715) | 2.19803592 |
92 | Golgi organization (GO:0007030) | 2.19601629 |
93 | eye photoreceptor cell differentiation (GO:0001754) | 2.19525383 |
94 | photoreceptor cell differentiation (GO:0046530) | 2.19525383 |
95 | keratan sulfate catabolic process (GO:0042340) | 2.18894298 |
96 | positive regulation of mitochondrial fission (GO:0090141) | 2.18636718 |
97 | response to leptin (GO:0044321) | 2.17892612 |
98 | nucleotide-sugar metabolic process (GO:0009225) | 2.17766517 |
99 | inositol phosphate catabolic process (GO:0071545) | 2.16962409 |
100 | response to endoplasmic reticulum stress (GO:0034976) | 2.16870880 |
101 | cholesterol biosynthetic process (GO:0006695) | 2.16293967 |
102 | positive regulation of glycolytic process (GO:0045821) | 2.15442186 |
103 | cilium morphogenesis (GO:0060271) | 2.15398983 |
104 | branched-chain amino acid catabolic process (GO:0009083) | 2.15216823 |
105 | regulation of protein glycosylation (GO:0060049) | 2.15072401 |
106 | beta-amyloid metabolic process (GO:0050435) | 2.14821931 |
107 | sequestering of metal ion (GO:0051238) | 2.14784705 |
108 | branched-chain amino acid metabolic process (GO:0009081) | 2.14757016 |
109 | aromatic amino acid family catabolic process (GO:0009074) | 2.14596895 |
110 | collagen fibril organization (GO:0030199) | 2.14161373 |
111 | regulation of insulin secretion (GO:0050796) | 2.13864234 |
112 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.13785556 |
113 | lactate metabolic process (GO:0006089) | 2.12162018 |
114 | positive regulation of fatty acid oxidation (GO:0046321) | 2.11519666 |
115 | regulation of fibrinolysis (GO:0051917) | 2.11408494 |
116 | sterol biosynthetic process (GO:0016126) | 2.11294257 |
117 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.09649414 |
118 | response to redox state (GO:0051775) | 2.09533685 |
119 | macroautophagy (GO:0016236) | 2.09495764 |
120 | protein carboxylation (GO:0018214) | 2.08882340 |
121 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.08882340 |
122 | melanosome transport (GO:0032402) | 2.08253351 |
123 | alanine transport (GO:0032328) | 2.08116111 |
124 | transcytosis (GO:0045056) | 2.08041736 |
125 | positive regulation of vesicle fusion (GO:0031340) | 2.08002730 |
126 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.07476097 |
127 | regulation of cilium movement (GO:0003352) | 2.07079588 |
128 | drug transmembrane transport (GO:0006855) | 2.06904946 |
129 | extracellular negative regulation of signal transduction (GO:1900116) | 2.06529304 |
130 | extracellular regulation of signal transduction (GO:1900115) | 2.06529304 |
131 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.06386875 |
132 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.06371996 |
133 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.06055156 |
134 | L-ascorbic acid metabolic process (GO:0019852) | 2.06053512 |
135 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.05829463 |
136 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.05829463 |
137 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.05748955 |
138 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.05378226 |
139 | protein deneddylation (GO:0000338) | 2.05126786 |
140 | cell redox homeostasis (GO:0045454) | 2.05020017 |
141 | positive regulation of insulin secretion (GO:0032024) | 2.04600239 |
142 | positive regulation of TOR signaling (GO:0032008) | 2.03731769 |
143 | intestinal cholesterol absorption (GO:0030299) | 2.03446265 |
144 | cellular modified amino acid catabolic process (GO:0042219) | 2.01206737 |
145 | negative regulation of glycogen metabolic process (GO:0070874) | 2.01110797 |
146 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.00752411 |
147 | type B pancreatic cell development (GO:0003323) | 2.00365993 |
148 | response to methylmercury (GO:0051597) | 2.00284741 |
149 | cellular response to glucagon stimulus (GO:0071377) | 2.00275763 |
150 | response to unfolded protein (GO:0006986) | 1.99133372 |
151 | peptide secretion (GO:0002790) | 1.99075292 |
152 | peptidyl-asparagine modification (GO:0018196) | 1.98333442 |
153 | regulation of synaptic vesicle exocytosis (GO:2000300) | 1.98273402 |
154 | chondrocyte development (GO:0002063) | 1.97468082 |
155 | presynaptic membrane assembly (GO:0097105) | 1.96983176 |
156 | inner ear receptor cell development (GO:0060119) | 1.96877228 |
157 | sulfur amino acid catabolic process (GO:0000098) | 1.96814163 |
158 | regulation of peptide hormone secretion (GO:0090276) | 1.96291078 |
159 | regulation of peptide secretion (GO:0002791) | 1.94959820 |
160 | protein N-linked glycosylation (GO:0006487) | 1.93823705 |
161 | peptide hormone secretion (GO:0030072) | 1.92880038 |
162 | hormone catabolic process (GO:0042447) | 1.92799501 |
163 | succinate metabolic process (GO:0006105) | 1.90612125 |
164 | response to topologically incorrect protein (GO:0035966) | 1.90381031 |
165 | short-chain fatty acid metabolic process (GO:0046459) | 1.89362314 |
166 | Golgi vesicle transport (GO:0048193) | 1.89334386 |
167 | regulation of energy homeostasis (GO:2000505) | 1.89290954 |
168 | regulation of beta-amyloid formation (GO:1902003) | 1.87932170 |
169 | positive regulation of glycogen biosynthetic process (GO:0045725) | 1.87586111 |
170 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 1.86852183 |
171 | negative regulation of neurotransmitter transport (GO:0051589) | 1.86051670 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.38317861 |
2 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.20849103 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13721745 |
4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12787864 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11974669 |
6 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.07581059 |
7 | FUS_26573619_Chip-Seq_HEK293_Human | 2.00867081 |
8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94651339 |
9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90971874 |
10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88473293 |
11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87630288 |
12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.85214428 |
13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.83496752 |
14 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.78264777 |
15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.77271788 |
16 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.71749544 |
17 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.70624673 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70390031 |
19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70153807 |
20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.69882181 |
21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.69875699 |
22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68584863 |
23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66208341 |
24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66051129 |
25 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.62198946 |
26 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.62198946 |
27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.61993713 |
28 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.59730130 |
29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59712932 |
30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53700965 |
31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51930019 |
32 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.48894441 |
33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47218752 |
34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46574525 |
35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45217238 |
36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43956334 |
37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43282344 |
38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.43003696 |
39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41434584 |
40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41067226 |
41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.40824184 |
42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39375666 |
43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38622445 |
44 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.38514812 |
45 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.37230194 |
46 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.35323547 |
47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35273304 |
48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.34985059 |
49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34150942 |
50 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33796949 |
51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33738745 |
52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.32797361 |
53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32434014 |
54 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.32183342 |
55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31806535 |
56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31247915 |
57 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30407928 |
58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30399882 |
59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29960774 |
60 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29593187 |
61 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28878510 |
62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27175216 |
63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26855629 |
64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26659012 |
65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25429894 |
66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24335091 |
67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22904280 |
68 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22708400 |
69 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22513212 |
70 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22356359 |
71 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22356359 |
72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21487926 |
73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20058398 |
74 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19582426 |
75 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18770832 |
76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18197504 |
77 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17573981 |
78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17258401 |
79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16368372 |
80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14387714 |
81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14038960 |
82 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13532212 |
83 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13456170 |
84 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13308945 |
85 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13101449 |
86 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.11024482 |
87 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10939177 |
88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10568961 |
89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10568961 |
90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10222080 |
91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09929183 |
92 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09506413 |
93 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.09081277 |
94 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.08982341 |
95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08727238 |
96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08597321 |
97 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08584749 |
98 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07134899 |
99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06991629 |
100 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06905057 |
101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06834536 |
102 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05858942 |
103 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05751667 |
104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05713542 |
105 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05502010 |
106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05069823 |
107 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05026162 |
108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05003502 |
109 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04805632 |
110 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03274108 |
111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03222240 |
112 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03218003 |
113 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02818574 |
114 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02484973 |
115 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01435550 |
116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01218931 |
117 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00959479 |
118 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00589930 |
119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00442984 |
120 | JUN_21703547_ChIP-Seq_K562_Human | 0.99764984 |
121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99613556 |
122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98745839 |
123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98488957 |
124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98327084 |
125 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97679764 |
126 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96846890 |
127 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96054008 |
128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95603999 |
129 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95310949 |
130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95191749 |
131 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94338133 |
132 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93127842 |
133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92939554 |
134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92803008 |
135 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92662979 |
136 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92573283 |
137 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91840288 |
138 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90257273 |
139 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90163762 |
140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88897357 |
141 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88239950 |
142 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87860275 |
143 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87524843 |
144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86750752 |
145 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86154978 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009780_abnormal_chondrocyte_physiolo | 3.72576164 |
2 | MP0003195_calcinosis | 3.46116376 |
3 | MP0004043_abnormal_pH_regulation | 3.37697206 |
4 | MP0006054_spinal_hemorrhage | 3.28863131 |
5 | MP0004272_abnormal_basement_membrane | 2.94606423 |
6 | MP0002909_abnormal_adrenal_gland | 2.92162858 |
7 | MP0002837_dystrophic_cardiac_calcinosis | 2.80651958 |
8 | MP0002139_abnormal_hepatobiliary_system | 2.76639881 |
9 | MP0000013_abnormal_adipose_tissue | 2.75597977 |
10 | MP0010386_abnormal_urinary_bladder | 2.41643462 |
11 | MP0005365_abnormal_bile_salt | 2.36928235 |
12 | MP0003283_abnormal_digestive_organ | 2.34907554 |
13 | MP0002877_abnormal_melanocyte_morpholog | 2.18695970 |
14 | MP0008438_abnormal_cutaneous_collagen | 2.07124372 |
15 | MP0005085_abnormal_gallbladder_physiolo | 2.04282716 |
16 | MP0005257_abnormal_intraocular_pressure | 1.91771908 |
17 | MP0003941_abnormal_skin_development | 1.91264673 |
18 | MP0002693_abnormal_pancreas_physiology | 1.82827884 |
19 | MP0001944_abnormal_pancreas_morphology | 1.80765393 |
20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.80136013 |
21 | MP0010234_abnormal_vibrissa_follicle | 1.79882131 |
22 | MP0005058_abnormal_lysosome_morphology | 1.77532802 |
23 | MP0003252_abnormal_bile_duct | 1.73218502 |
24 | MP0002102_abnormal_ear_morphology | 1.68157634 |
25 | MP0002896_abnormal_bone_mineralization | 1.66897910 |
26 | MP0003183_abnormal_peptide_metabolism | 1.65904852 |
27 | MP0005360_urolithiasis | 1.65698916 |
28 | MP0001765_abnormal_ion_homeostasis | 1.61138278 |
29 | MP0005379_endocrine/exocrine_gland_phen | 1.60058181 |
30 | MP0001666_abnormal_nutrient_absorption | 1.55154916 |
31 | MP0005220_abnormal_exocrine_pancreas | 1.54956865 |
32 | MP0003868_abnormal_feces_composition | 1.52186611 |
33 | MP0005503_abnormal_tendon_morphology | 1.51074401 |
34 | MP0002876_abnormal_thyroid_physiology | 1.50523304 |
35 | MP0005367_renal/urinary_system_phenotyp | 1.47308663 |
36 | MP0000516_abnormal_urinary_system | 1.47308663 |
37 | MP0002078_abnormal_glucose_homeostasis | 1.46623108 |
38 | MP0000003_abnormal_adipose_tissue | 1.46334442 |
39 | MP0001986_abnormal_taste_sensitivity | 1.45768103 |
40 | MP0003329_amyloid_beta_deposits | 1.42284395 |
41 | MP0003880_abnormal_central_pattern | 1.37505691 |
42 | MP0005253_abnormal_eye_physiology | 1.36673892 |
43 | MP0005332_abnormal_amino_acid | 1.36045984 |
44 | MP0003950_abnormal_plasma_membrane | 1.35344602 |
45 | MP0010678_abnormal_skin_adnexa | 1.34372554 |
46 | MP0004270_analgesia | 1.32689994 |
47 | MP0009697_abnormal_copulation | 1.31858591 |
48 | MP0005646_abnormal_pituitary_gland | 1.30244149 |
49 | MP0005083_abnormal_biliary_tract | 1.28431845 |
50 | MP0001501_abnormal_sleep_pattern | 1.28341960 |
51 | MP0010352_gastrointestinal_tract_polyps | 1.28311835 |
52 | MP0004215_abnormal_myocardial_fiber | 1.26822230 |
53 | MP0003300_gastrointestinal_ulcer | 1.24778153 |
54 | MP0005535_abnormal_body_temperature | 1.24032076 |
55 | MP0003787_abnormal_imprinting | 1.23274419 |
56 | MP0005408_hypopigmentation | 1.20168406 |
57 | MP0002118_abnormal_lipid_homeostasis | 1.19811124 |
58 | MP0009643_abnormal_urine_homeostasis | 1.19722606 |
59 | MP0003279_aneurysm | 1.18358808 |
60 | MP0003690_abnormal_glial_cell | 1.18297743 |
61 | MP0005275_abnormal_skin_tensile | 1.17457087 |
62 | MP0001958_emphysema | 1.17160160 |
63 | MP0002295_abnormal_pulmonary_circulatio | 1.16309615 |
64 | MP0003121_genomic_imprinting | 1.13575708 |
65 | MP0005551_abnormal_eye_electrophysiolog | 1.13237219 |
66 | MP0004019_abnormal_vitamin_homeostasis | 1.12111213 |
67 | MP0002638_abnormal_pupillary_reflex | 1.11794596 |
68 | MP0002928_abnormal_bile_duct | 1.11399977 |
69 | MP0005084_abnormal_gallbladder_morpholo | 1.11079458 |
70 | MP0010329_abnormal_lipoprotein_level | 1.08844001 |
71 | MP0005636_abnormal_mineral_homeostasis | 1.06040066 |
72 | MP0001661_extended_life_span | 1.04953436 |
73 | MP0000230_abnormal_systemic_arterial | 1.04714208 |
74 | MP0009384_cardiac_valve_regurgitation | 1.04421696 |
75 | MP0005623_abnormal_meninges_morphology | 1.03344651 |
76 | MP0005645_abnormal_hypothalamus_physiol | 1.03127312 |
77 | MP0002064_seizures | 1.02980164 |
78 | MP0000538_abnormal_urinary_bladder | 1.01709820 |
79 | MP0005187_abnormal_penis_morphology | 1.01405890 |
80 | MP0000427_abnormal_hair_cycle | 0.99762923 |
81 | MP0003633_abnormal_nervous_system | 0.99122308 |
82 | MP0003953_abnormal_hormone_level | 0.98406501 |
83 | MP0003635_abnormal_synaptic_transmissio | 0.98139250 |
84 | MP0009046_muscle_twitch | 0.97554757 |
85 | MP0003172_abnormal_lysosome_physiology | 0.97179860 |
86 | MP0004036_abnormal_muscle_relaxation | 0.96605583 |
87 | MP0001664_abnormal_digestion | 0.96392782 |
88 | MP0010368_abnormal_lymphatic_system | 0.96358025 |
89 | MP0000920_abnormal_myelination | 0.95262575 |
90 | MP0003186_abnormal_redox_activity | 0.95079193 |
91 | MP0001756_abnormal_urination | 0.95058806 |
92 | MP0004859_abnormal_synaptic_plasticity | 0.93987055 |
93 | MP0001299_abnormal_eye_distance/ | 0.93269941 |
94 | MP0000604_amyloidosis | 0.93092304 |
95 | MP0008775_abnormal_heart_ventricle | 0.92833951 |
96 | MP0004145_abnormal_muscle_electrophysio | 0.92815499 |
97 | MP0003122_maternal_imprinting | 0.91719070 |
98 | MP0000462_abnormal_digestive_system | 0.91083398 |
99 | MP0005164_abnormal_response_to | 0.89507051 |
100 | MP0004264_abnormal_extraembryonic_tissu | 0.88555680 |
101 | MP0002060_abnormal_skin_morphology | 0.87847586 |
102 | MP0003959_abnormal_lean_body | 0.87796791 |
103 | MP0002272_abnormal_nervous_system | 0.87387427 |
104 | MP0008961_abnormal_basal_metabolism | 0.86827037 |
105 | MP0000751_myopathy | 0.85522121 |
106 | MP0003045_fibrosis | 0.84888108 |
107 | MP0004134_abnormal_chest_morphology | 0.84293656 |
108 | MP0003011_delayed_dark_adaptation | 0.84118298 |
109 | MP0009745_abnormal_behavioral_response | 0.83480954 |
110 | MP0005334_abnormal_fat_pad | 0.83397815 |
111 | MP0002063_abnormal_learning/memory/cond | 0.83138565 |
112 | MP0006072_abnormal_retinal_apoptosis | 0.83090660 |
113 | MP0005310_abnormal_salivary_gland | 0.83082463 |
114 | MP0002168_other_aberrant_phenotype | 0.81135281 |
115 | MP0001270_distended_abdomen | 0.81127986 |
116 | MP0003634_abnormal_glial_cell | 0.80989940 |
117 | MP0001502_abnormal_circadian_rhythm | 0.79969280 |
118 | MP0004130_abnormal_muscle_cell | 0.79642625 |
119 | MP0002572_abnormal_emotion/affect_behav | 0.79274414 |
120 | MP0005448_abnormal_energy_balance | 0.79170874 |
121 | MP0001243_abnormal_dermal_layer | 0.79046855 |
122 | MP0004233_abnormal_muscle_weight | 0.78894119 |
123 | MP0003123_paternal_imprinting | 0.78808305 |
124 | MP0004782_abnormal_surfactant_physiolog | 0.78533745 |
125 | MP0000647_abnormal_sebaceous_gland | 0.78369367 |
126 | MP0002229_neurodegeneration | 0.77982218 |
127 | MP0001177_atelectasis | 0.77782513 |
128 | MP0002938_white_spotting | 0.76092224 |
129 | MP0005375_adipose_tissue_phenotype | 0.75854199 |
130 | MP0005395_other_phenotype | 0.75216762 |
131 | MP0004885_abnormal_endolymph | 0.74980243 |
132 | MP0008877_abnormal_DNA_methylation | 0.74725672 |
133 | MP0005508_abnormal_skeleton_morphology | 0.74238280 |
134 | MP0000163_abnormal_cartilage_morphology | 0.73534547 |
135 | MP0003937_abnormal_limbs/digits/tail_de | 0.72995294 |
136 | MP0002163_abnormal_gland_morphology | 0.72827936 |
137 | MP0003566_abnormal_cell_adhesion | 0.72807399 |
138 | MP0004085_abnormal_heartbeat | 0.72422457 |
139 | MP0002090_abnormal_vision | 0.72022449 |
140 | MP0000747_muscle_weakness | 0.71931331 |
141 | MP0005319_abnormal_enzyme/_coenzyme | 0.70330439 |
142 | MP0002734_abnormal_mechanical_nocicepti | 0.70242634 |
143 | MP0000639_abnormal_adrenal_gland | 0.69842300 |
144 | MP0003879_abnormal_hair_cell | 0.69529326 |
145 | MP0001542_abnormal_bone_strength | 0.69397749 |
146 | MP0001984_abnormal_olfaction | 0.68869677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic seizures (HP:0002173) | 4.14348577 |
2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.93384514 |
3 | Ketoacidosis (HP:0001993) | 3.69057110 |
4 | Hypoglycemic coma (HP:0001325) | 3.64460180 |
5 | Symptomatic seizures (HP:0011145) | 3.62498742 |
6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.61777006 |
7 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.39362040 |
8 | Mucopolysacchariduria (HP:0008155) | 3.39362040 |
9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.34798170 |
10 | Dysostosis multiplex (HP:0000943) | 3.21696264 |
11 | Abnormality of the intrinsic pathway (HP:0010989) | 3.08328594 |
12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.06223652 |
13 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.06223652 |
14 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.06223652 |
15 | Protuberant abdomen (HP:0001538) | 2.87947354 |
16 | Ketosis (HP:0001946) | 2.81415702 |
17 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.79769080 |
18 | Epiphyseal dysplasia (HP:0002656) | 2.75159853 |
19 | Short tibia (HP:0005736) | 2.73766879 |
20 | Hyperglycemia (HP:0003074) | 2.71844888 |
21 | Medial flaring of the eyebrow (HP:0010747) | 2.61106184 |
22 | Mitral stenosis (HP:0001718) | 2.58619706 |
23 | Large for gestational age (HP:0001520) | 2.52986172 |
24 | Neurofibrillary tangles (HP:0002185) | 2.49182584 |
25 | Cardiovascular calcification (HP:0011915) | 2.47728449 |
26 | Intestinal atresia (HP:0011100) | 2.44881260 |
27 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.43397627 |
28 | Methylmalonic acidemia (HP:0002912) | 2.37085907 |
29 | Increased serum pyruvate (HP:0003542) | 2.36048674 |
30 | Agitation (HP:0000713) | 2.34441738 |
31 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.33837908 |
32 | Delayed gross motor development (HP:0002194) | 2.33221579 |
33 | Skin nodule (HP:0200036) | 2.33173801 |
34 | Congenital primary aphakia (HP:0007707) | 2.33118430 |
35 | Generalized aminoaciduria (HP:0002909) | 2.32911474 |
36 | Abnormal tarsal ossification (HP:0008369) | 2.32715522 |
37 | Retinal atrophy (HP:0001105) | 2.31961862 |
38 | Proximal tubulopathy (HP:0000114) | 2.30916294 |
39 | Abnormality of dentin (HP:0010299) | 2.28906506 |
40 | Ovoid vertebral bodies (HP:0003300) | 2.28060757 |
41 | Vascular calcification (HP:0004934) | 2.26800309 |
42 | Follicular hyperkeratosis (HP:0007502) | 2.26660275 |
43 | Aortic dissection (HP:0002647) | 2.26354611 |
44 | Gait imbalance (HP:0002141) | 2.25541907 |
45 | Tetraparesis (HP:0002273) | 2.25449677 |
46 | Neuroendocrine neoplasm (HP:0100634) | 2.25079770 |
47 | Type I transferrin isoform profile (HP:0003642) | 2.21379239 |
48 | Decreased circulating renin level (HP:0003351) | 2.20889950 |
49 | Hypokinesia (HP:0002375) | 2.20073032 |
50 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19502687 |
51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18987624 |
52 | Pheochromocytoma (HP:0002666) | 2.15846928 |
53 | Hypoplastic ischia (HP:0003175) | 2.14142054 |
54 | Abnormality of vitamin B metabolism (HP:0004340) | 2.13765017 |
55 | Protrusio acetabuli (HP:0003179) | 2.13260886 |
56 | Gout (HP:0001997) | 2.13044459 |
57 | Type II lissencephaly (HP:0007260) | 2.12874942 |
58 | Disproportionate short-trunk short stature (HP:0003521) | 2.12448665 |
59 | Abnormality of the ischium (HP:0003174) | 2.11247241 |
60 | Hypobetalipoproteinemia (HP:0003563) | 2.10499932 |
61 | Atonic seizures (HP:0010819) | 2.09313780 |
62 | Hydroxyprolinuria (HP:0003080) | 2.08067626 |
63 | Abnormality of proline metabolism (HP:0010907) | 2.08067626 |
64 | Xanthomatosis (HP:0000991) | 2.07236569 |
65 | Intrahepatic cholestasis (HP:0001406) | 2.06598343 |
66 | Abnormality of vitamin metabolism (HP:0100508) | 2.06499867 |
67 | Cerebral inclusion bodies (HP:0100314) | 2.05507813 |
68 | Hypokalemia (HP:0002900) | 2.04611375 |
69 | Hypolipoproteinemia (HP:0010981) | 2.03413688 |
70 | Beaking of vertebral bodies (HP:0004568) | 2.02403626 |
71 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.01666778 |
72 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.01666778 |
73 | Vascular tortuosity (HP:0004948) | 1.99576800 |
74 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98646454 |
75 | Abnormality of glycolysis (HP:0004366) | 1.97727026 |
76 | Ankle contracture (HP:0006466) | 1.94192911 |
77 | Metaphyseal dysplasia (HP:0100255) | 1.93049556 |
78 | Intention tremor (HP:0002080) | 1.92664005 |
79 | Progressive neurologic deterioration (HP:0002344) | 1.92345862 |
80 | Increased circulating renin level (HP:0000848) | 1.92097258 |
81 | Thyroid carcinoma (HP:0002890) | 1.91264779 |
82 | Global brain atrophy (HP:0002283) | 1.91255136 |
83 | Tongue fasciculations (HP:0001308) | 1.88603770 |
84 | Diminished movement (HP:0002374) | 1.88070251 |
85 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.87896265 |
86 | Hyperactive renin-angiotensin system (HP:0000841) | 1.87871677 |
87 | Abdominal distention (HP:0003270) | 1.87851632 |
88 | Papilledema (HP:0001085) | 1.87751450 |
89 | Abnormality of renin-angiotensin system (HP:0000847) | 1.86859939 |
90 | Oligomenorrhea (HP:0000876) | 1.86009055 |
91 | Abnormality of methionine metabolism (HP:0010901) | 1.84924040 |
92 | Vacuolated lymphocytes (HP:0001922) | 1.84880268 |
93 | Fat malabsorption (HP:0002630) | 1.83605327 |
94 | Hyperkalemia (HP:0002153) | 1.83457941 |
95 | Abnormality of potassium homeostasis (HP:0011042) | 1.82804864 |
96 | Abnormality of purine metabolism (HP:0004352) | 1.82174358 |
97 | Epidermoid cyst (HP:0200040) | 1.82097066 |
98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.79782659 |
99 | Arterial tortuosity (HP:0005116) | 1.79301615 |
100 | Hypoalphalipoproteinemia (HP:0003233) | 1.79193827 |
101 | Renal cortical cysts (HP:0000803) | 1.78139552 |
102 | Hypokalemic alkalosis (HP:0001949) | 1.77717762 |
103 | Occipital encephalocele (HP:0002085) | 1.77520669 |
104 | Progressive macrocephaly (HP:0004481) | 1.77252346 |
105 | Late onset (HP:0003584) | 1.76795424 |
106 | Genital tract atresia (HP:0001827) | 1.76665107 |
107 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.76484412 |
108 | Hypoplasia of the fovea (HP:0007750) | 1.76484412 |
109 | Methylmalonic aciduria (HP:0012120) | 1.76177105 |
110 | Papillary thyroid carcinoma (HP:0002895) | 1.75676852 |
111 | Rhinitis (HP:0012384) | 1.75384245 |
112 | Focal motor seizures (HP:0011153) | 1.74905161 |
113 | Cervical subluxation (HP:0003308) | 1.73948376 |
114 | Prolonged partial thromboplastin time (HP:0003645) | 1.73883941 |
115 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.72176969 |
116 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.72176969 |
117 | Abnormal protein glycosylation (HP:0012346) | 1.72176969 |
118 | Abnormal glycosylation (HP:0012345) | 1.72176969 |
119 | Deep venous thrombosis (HP:0002625) | 1.71618131 |
120 | Hemiparesis (HP:0001269) | 1.71513364 |
121 | Osteomalacia (HP:0002749) | 1.70994915 |
122 | Soft skin (HP:0000977) | 1.70497578 |
123 | Testicular neoplasm (HP:0010788) | 1.70209723 |
124 | Palpitations (HP:0001962) | 1.70138091 |
125 | Hyperlipoproteinemia (HP:0010980) | 1.69450736 |
126 | Absence seizures (HP:0002121) | 1.69394703 |
127 | EEG with generalized epileptiform discharges (HP:0011198) | 1.68285336 |
128 | Epileptic encephalopathy (HP:0200134) | 1.68131523 |
129 | Microglossia (HP:0000171) | 1.67645201 |
130 | Exocrine pancreatic insufficiency (HP:0001738) | 1.65127050 |
131 | Postural tremor (HP:0002174) | 1.65042221 |
132 | Vaginal atresia (HP:0000148) | 1.64872748 |
133 | Asymmetric septal hypertrophy (HP:0001670) | 1.64652584 |
134 | Abnormality of chloride homeostasis (HP:0011422) | 1.64329604 |
135 | Epileptiform EEG discharges (HP:0011182) | 1.64259779 |
136 | Irregular vertebral endplates (HP:0003301) | 1.64252966 |
137 | Abnormal pancreas size (HP:0012094) | 1.63570724 |
138 | Visual hallucinations (HP:0002367) | 1.62815499 |
139 | Pancreatic fibrosis (HP:0100732) | 1.62366249 |
140 | Retinal dysplasia (HP:0007973) | 1.62264294 |
141 | Abnormality of the vitreous humor (HP:0004327) | 1.62150131 |
142 | Premature rupture of membranes (HP:0001788) | 1.60902938 |
143 | Hypsarrhythmia (HP:0002521) | 1.60098748 |
144 | Abnormal foot bone ossification (HP:0010675) | 1.58870992 |
145 | Osteoarthritis (HP:0002758) | 1.58634419 |
146 | Muscular hypotonia of the trunk (HP:0008936) | 1.58566582 |
147 | Aplasia involving bones of the extremities (HP:0009825) | 1.58443913 |
148 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.58443913 |
149 | Aplasia of the phalanges of the hand (HP:0009802) | 1.58443913 |
150 | Congenital glaucoma (HP:0001087) | 1.57899387 |
151 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.57493941 |
152 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.57046288 |
153 | Bronchomalacia (HP:0002780) | 1.56993605 |
154 | Thoracolumbar scoliosis (HP:0002944) | 1.56962377 |
155 | Abnormality of the fovea (HP:0000493) | 1.56199191 |
156 | Hypothermia (HP:0002045) | 1.56139760 |
157 | Macroorchidism (HP:0000053) | 1.55490734 |
158 | Action tremor (HP:0002345) | 1.54998095 |
159 | Exercise-induced muscle cramps (HP:0003710) | 1.54173689 |
160 | Metaphyseal irregularity (HP:0003025) | 1.53919201 |
161 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.53796409 |
162 | Postaxial hand polydactyly (HP:0001162) | 1.52418963 |
163 | Hypophosphatemia (HP:0002148) | 1.51824546 |
164 | Hyperphosphatemia (HP:0002905) | 1.51468929 |
165 | Acute hepatic failure (HP:0006554) | 1.50973207 |
166 | Dialeptic seizures (HP:0011146) | 1.48728130 |
167 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.47908172 |
168 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.47908172 |
Rank | Gene Set | Z-score |
---|---|---|
1 | INSRR | 4.29075655 |
2 | TRIM28 | 3.71622258 |
3 | MAPK15 | 3.04669260 |
4 | WNK4 | 2.99393097 |
5 | FRK | 2.86319836 |
6 | MAP3K12 | 2.70250892 |
7 | LIMK1 | 2.64804840 |
8 | EIF2AK3 | 2.62939472 |
9 | STK39 | 2.49871628 |
10 | TAOK3 | 2.41218726 |
11 | MAP3K2 | 2.38271166 |
12 | BCKDK | 2.05129028 |
13 | PRKD3 | 1.95434723 |
14 | TESK1 | 1.94268444 |
15 | NTRK1 | 1.80862244 |
16 | NTRK3 | 1.79485248 |
17 | ERN1 | 1.75932863 |
18 | NEK1 | 1.72157177 |
19 | OXSR1 | 1.68980178 |
20 | STK38L | 1.68519560 |
21 | MAPK13 | 1.64412656 |
22 | PASK | 1.55571535 |
23 | PDK3 | 1.55531957 |
24 | PDK4 | 1.55531957 |
25 | CSNK1G1 | 1.52473743 |
26 | EPHA3 | 1.49620131 |
27 | PAK3 | 1.49450890 |
28 | PDK2 | 1.46721097 |
29 | MAPKAPK3 | 1.46175160 |
30 | CSNK1G3 | 1.44288207 |
31 | MAP4K2 | 1.43479360 |
32 | IRAK1 | 1.40824932 |
33 | NME1 | 1.37934018 |
34 | AKT3 | 1.37209121 |
35 | HIPK2 | 1.36751285 |
36 | DDR2 | 1.33331292 |
37 | SIK1 | 1.26598601 |
38 | WNK1 | 1.23276991 |
39 | EPHB1 | 1.18859445 |
40 | IRAK3 | 1.18727265 |
41 | MAP2K7 | 1.15656400 |
42 | ERBB3 | 1.14907943 |
43 | MAP3K1 | 1.14721126 |
44 | GRK1 | 1.13155677 |
45 | IRAK2 | 1.12794047 |
46 | MET | 1.09125731 |
47 | SCYL2 | 1.06769555 |
48 | PRKCH | 1.06447912 |
49 | SGK223 | 1.00522017 |
50 | SGK494 | 1.00522017 |
51 | STK3 | 1.00280431 |
52 | FER | 0.99424993 |
53 | PLK3 | 0.98561211 |
54 | EIF2AK1 | 0.98331899 |
55 | PTK6 | 0.97826820 |
56 | TRIB3 | 0.96794037 |
57 | PRKCE | 0.96749716 |
58 | SIK3 | 0.96376243 |
59 | BCR | 0.95817187 |
60 | FLT3 | 0.92943544 |
61 | KSR2 | 0.92174046 |
62 | MAP2K4 | 0.89691498 |
63 | PDGFRA | 0.88511424 |
64 | EPHA4 | 0.88372961 |
65 | BMPR2 | 0.86527486 |
66 | BRSK2 | 0.86519854 |
67 | TGFBR2 | 0.85731039 |
68 | MST4 | 0.85249845 |
69 | MAP3K4 | 0.85163386 |
70 | BMPR1B | 0.84015905 |
71 | PIK3CG | 0.82845957 |
72 | ADRBK2 | 0.82184429 |
73 | TRPM7 | 0.81863219 |
74 | ROCK1 | 0.81388293 |
75 | PTK2 | 0.80652464 |
76 | CAMK2D | 0.79512300 |
77 | PTK2B | 0.79150387 |
78 | WNK3 | 0.78756239 |
79 | CAMKK2 | 0.78698874 |
80 | ROCK2 | 0.77811832 |
81 | UHMK1 | 0.77571056 |
82 | PINK1 | 0.76798959 |
83 | MST1R | 0.75623284 |
84 | PNCK | 0.74684523 |
85 | FGFR2 | 0.73903597 |
86 | CDC42BPA | 0.73469893 |
87 | NEK9 | 0.70626283 |
88 | SGK2 | 0.70033247 |
89 | RET | 0.69574991 |
90 | ACVR1B | 0.68999667 |
91 | JAK1 | 0.68857949 |
92 | MAP2K1 | 0.67674807 |
93 | SGK3 | 0.67010249 |
94 | ARAF | 0.66746940 |
95 | EPHA2 | 0.66635547 |
96 | CAMK2A | 0.65158336 |
97 | DAPK1 | 0.64422876 |
98 | LMTK2 | 0.63186778 |
99 | NUAK1 | 0.63067104 |
100 | CDK5 | 0.59783375 |
101 | PAK6 | 0.59287529 |
102 | JAK2 | 0.58549325 |
103 | FGFR1 | 0.58544874 |
104 | PHKG2 | 0.58473259 |
105 | PHKG1 | 0.58473259 |
106 | PDPK1 | 0.57516400 |
107 | CAMKK1 | 0.55551152 |
108 | PRKCQ | 0.55139028 |
109 | DAPK2 | 0.54849886 |
110 | CAMK1G | 0.53789443 |
111 | CAMK2B | 0.52652585 |
112 | CAMK2G | 0.52342618 |
113 | CSNK1G2 | 0.52184391 |
114 | LATS1 | 0.51744757 |
115 | GRK5 | 0.51164611 |
116 | WEE1 | 0.51086400 |
117 | PAK4 | 0.50046162 |
118 | PLK2 | 0.49912395 |
119 | FGFR3 | 0.48895615 |
120 | RPS6KA4 | 0.48561886 |
121 | MAPK7 | 0.48373551 |
122 | CASK | 0.47998044 |
123 | MAP3K3 | 0.47261439 |
124 | SGK1 | 0.47239405 |
125 | NEK6 | 0.46835899 |
126 | MYLK | 0.45642467 |
127 | PIK3CA | 0.44170023 |
128 | STK24 | 0.43915864 |
129 | CSNK1A1L | 0.43763774 |
130 | ADRBK1 | 0.43588988 |
131 | TNK2 | 0.43245408 |
132 | PRKCG | 0.42588524 |
133 | MINK1 | 0.42366954 |
134 | ERBB4 | 0.42244179 |
135 | CSNK1A1 | 0.41613466 |
136 | PDK1 | 0.41264641 |
137 | TIE1 | 0.40881568 |
138 | SRPK1 | 0.40719599 |
139 | STK38 | 0.40704001 |
140 | MARK1 | 0.37341069 |
141 | BRSK1 | 0.37171296 |
142 | EIF2AK2 | 0.36786184 |
143 | PRKAA1 | 0.36201644 |
144 | PRKG1 | 0.32174176 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.77083245 |
2 | Protein export_Homo sapiens_hsa03060 | 3.10074820 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.09269086 |
4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.16881283 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88531775 |
6 | Insulin secretion_Homo sapiens_hsa04911 | 1.88086122 |
7 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.82825793 |
8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.69464867 |
9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.59285843 |
10 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.56714474 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55930118 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47264404 |
13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46028177 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.44857152 |
15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31218395 |
16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29906663 |
17 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.23851748 |
18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22482676 |
19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22275808 |
20 | Lysosome_Homo sapiens_hsa04142 | 1.22179019 |
21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17151333 |
22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.17145450 |
23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15817902 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15658693 |
25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.13510748 |
26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.13316823 |
27 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.10702595 |
28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09576644 |
29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08123878 |
30 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.06516310 |
31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06461568 |
32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05259315 |
33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.04448048 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01662876 |
35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99266206 |
36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98931427 |
37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98563153 |
38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96144116 |
39 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95698235 |
40 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.95228704 |
41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94902886 |
42 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94761880 |
43 | Bile secretion_Homo sapiens_hsa04976 | 0.92280725 |
44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90843089 |
45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90398381 |
46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89673341 |
47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89146806 |
48 | Mineral absorption_Homo sapiens_hsa04978 | 0.88819848 |
49 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87204457 |
50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87026470 |
51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85887446 |
52 | Taste transduction_Homo sapiens_hsa04742 | 0.85702908 |
53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85224653 |
54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85059476 |
55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84603000 |
56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84302900 |
57 | Peroxisome_Homo sapiens_hsa04146 | 0.83911928 |
58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83725144 |
59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80865372 |
60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80716158 |
61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80231838 |
62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78229831 |
63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77998286 |
64 | Renin secretion_Homo sapiens_hsa04924 | 0.77214911 |
65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76763282 |
66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75232034 |
67 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74959713 |
68 | Morphine addiction_Homo sapiens_hsa05032 | 0.74062783 |
69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73601135 |
70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73242171 |
71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72006804 |
72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71824667 |
73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71771482 |
74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71679351 |
75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71406857 |
76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71254977 |
77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70655899 |
78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70622736 |
79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70509979 |
80 | ABC transporters_Homo sapiens_hsa02010 | 0.70086854 |
81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68651912 |
82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68651304 |
83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67875116 |
84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66808263 |
85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66534249 |
86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65463936 |
87 | Salivary secretion_Homo sapiens_hsa04970 | 0.65211353 |
88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64986011 |
89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64813817 |
90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64795836 |
91 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62869157 |
92 | Phototransduction_Homo sapiens_hsa04744 | 0.61508993 |
93 | Proteasome_Homo sapiens_hsa03050 | 0.61279414 |
94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60941268 |
95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60574899 |
96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60150938 |
97 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59702341 |
98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59344569 |
99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59083712 |
100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58179548 |
101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57300864 |
102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56774779 |
103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56624538 |
104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56443047 |
105 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55048172 |
106 | Insulin resistance_Homo sapiens_hsa04931 | 0.54228528 |
107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53862955 |
108 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52725634 |
109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52384340 |
110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52164915 |
111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51939604 |
112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51694531 |
113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50569744 |
114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50133709 |
115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48773792 |
116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48457048 |
117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47990320 |
118 | Long-term depression_Homo sapiens_hsa04730 | 0.47969380 |
119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46317417 |
120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46203162 |
121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44932908 |
122 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44248892 |
123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43948415 |
124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43665956 |
125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43536228 |
126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41483694 |
127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41404063 |
128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41245351 |
129 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38703469 |
130 | Tight junction_Homo sapiens_hsa04530 | 0.36331190 |